中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | 1,3-dibenzoyl-5-fluorouracil | 61289-10-9 | C18H11FN2O4 | 338.295 |
中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
---|---|---|---|---|
—— | 1,3-dibenzoyl-5-fluorouracil | 61289-10-9 | C18H11FN2O4 | 338.295 |
—— | 3-Benzoyl-5-fluoro-1-prop-2-ynylpyrimidine-2,4-dione | 449152-76-5 | C14H9FN2O3 | 272.235 |
—— | 1-Acetyl-3-benzoyl-5-fluoropyrimidine-2,4-dione | 75410-10-5 | C13H9FN2O4 | 276.224 |
—— | 3-Benzoyl-5-fluoro-1-propionyl-1H-pyrimidine-2,4-dione | 75410-11-6 | C14H11FN2O4 | 290.251 |
—— | N3-benzoyl-N1-[(Z)-4-dimethoxyphosphonylbut-2-enyl]-5-fluorouracil | 1260072-60-3 | C17H18FN2O6P | 396.312 |
—— | N3-benzoyl-N1-[(E)-4-dimethoxyphosphonylbut-2-enyl]-5-fluorouracil | 1260072-58-9 | C17H18FN2O6P | 396.312 |
—— | Ethyl 3-benzoyl-5-fluoro-2,4-dioxopyrimidine-1-carboxylate | 75410-17-2 | C14H11FN2O5 | 306.25 |
—— | 3-benzoyl-5-fluoro-1-octadecanoyl-1H-pyrimidine-2,4-dione | 61251-82-9 | C29H41FN2O4 | 500.654 |
—— | N3-benzoyl-N1-[(E)-5-diethoxyphosphonyl-pent-2-enyl]-5-fluorouracil | 1260072-63-6 | C20H24FN2O6P | 438.393 |
—— | 3-Benzoyl-5-fluoro-2,4-dioxo-3,4-dihydro-2H-pyrimidine-1-carboxylic acid phenyl ester | 75422-83-2 | C18H11FN2O5 | 354.294 |
—— | 3-Benzoyl-5-fluoro-1-(2-trityloxy-1-trityloxymethyl-ethyl)-1H-pyrimidine-2,4-dione | 210760-39-7 | C52H41FN2O5 | 792.906 |
—— | 3-Benzoyl-5-fluoro-1-((4aR,7S,8aS)-2-phenyl-hexahydro-pyrano[3,2-d][1,3]dioxin-7-yl)-1H-pyrimidine-2,4-dione | 1054629-17-2 | C24H21FN2O6 | 452.439 |
A novel class of difluorinated cyclopropanoic nucleoside analogues containing a hydroxypropyl group and a methylene spacer between the difluorocyclopropane ring and the heterocycle has been prepared.
A novel class of trans-configurated difluorinated cyclopropanoic nucleoside analogues containing a methylene spacer between the cyclopropane ring and the heterocycle has been prepared. Some of these compounds showed weak anti-HIV activity in preliminary screenings.
A novel class of nucleoside analogues containing adenine, uracil, thymine and 5-fluorouracil as the heterocyclic moieties have been prepared from 2-phenylcyclopropane carboxylic acid. These compounds showed weak antitum or activity. The resolution of the racemates on an analytical and semipreparative scale was performed by HPLC using chiral stationary phases.